Notice of Republication
This article was republished on September 15, 2014, to correct typesetting errors involving missing minus symbols throughout the text and tables. The publisher apologizes for these errors. Please download this article again to view the article. The originally published, uncorrected article and the republished, corrected article are provided here for reference.
Supporting Information
File S1.
Originally published, uncorrected article
https://doi.org/10.1371/journal.pone.0110069.s001
Reference
Citation: The PLOS ONE Staff (2014) Correction: Pharmacodynamic Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, from a Randomized Study in Patients with Type 2 Diabetes. PLoS ONE 9(9): e110069. https://doi.org/10.1371/journal.pone.0110069
Published: September 30, 2014
Copyright: © 2014 The PLOS ONE Staff. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.